JMP Securities started coverage on shares of Addus HomeCare (NASDAQ:ADUS – Free Report) in a research report sent to investors on Monday morning, MarketBeat reports. The brokerage issued an outperform rating and a $150.00 price objective on the stock.
A number of other research analysts have also weighed in on ADUS. Macquarie reissued an “outperform” rating and issued a $139.00 target price on shares of Addus HomeCare in a research note on Monday, November 4th. Oppenheimer raised their target price on shares of Addus HomeCare from $140.00 to $145.00 and gave the stock an “outperform” rating in a research note on Monday, September 23rd. StockNews.com raised shares of Addus HomeCare from a “hold” rating to a “buy” rating in a research note on Wednesday, December 11th. Stephens raised their target price on shares of Addus HomeCare from $143.00 to $145.00 and gave the stock an “overweight” rating in a research note on Wednesday, November 6th. Finally, Royal Bank of Canada reissued an “outperform” rating and issued a $136.00 target price on shares of Addus HomeCare in a research note on Thursday, November 14th. One analyst has rated the stock with a sell rating, nine have assigned a buy rating and one has issued a strong buy rating to the company. According to MarketBeat.com, Addus HomeCare presently has a consensus rating of “Moderate Buy” and an average target price of $133.67.
Read Our Latest Analysis on Addus HomeCare
Addus HomeCare Stock Up 4.3 %
Addus HomeCare (NASDAQ:ADUS – Get Free Report) last issued its quarterly earnings results on Monday, November 4th. The company reported $1.30 earnings per share for the quarter, beating analysts’ consensus estimates of $1.28 by $0.02. The firm had revenue of $289.80 million for the quarter, compared to analyst estimates of $289.42 million. Addus HomeCare had a net margin of 6.50% and a return on equity of 9.62%. Addus HomeCare’s quarterly revenue was up 7.1% compared to the same quarter last year. During the same period last year, the company posted $1.03 EPS. On average, analysts anticipate that Addus HomeCare will post 4.59 earnings per share for the current fiscal year.
Insider Buying and Selling
In other Addus HomeCare news, EVP Roberton James Stevenson sold 2,250 shares of Addus HomeCare stock in a transaction on Monday, December 9th. The shares were sold at an average price of $121.00, for a total transaction of $272,250.00. Following the completion of the transaction, the executive vice president now directly owns 10,217 shares of the company’s stock, valued at $1,236,257. The trade was a 18.05 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, CEO R Dirk Allison sold 12,500 shares of the business’s stock in a transaction dated Monday, November 25th. The shares were sold at an average price of $123.16, for a total transaction of $1,539,500.00. Following the completion of the sale, the chief executive officer now directly owns 141,897 shares of the company’s stock, valued at approximately $17,476,034.52. The trade was a 8.10 % decrease in their position. The disclosure for this sale can be found here. 4.60% of the stock is owned by insiders.
Institutional Investors Weigh In On Addus HomeCare
Several large investors have recently made changes to their positions in the business. Connor Clark & Lunn Investment Management Ltd. purchased a new position in Addus HomeCare in the 3rd quarter worth approximately $1,622,000. Dimensional Fund Advisors LP raised its holdings in Addus HomeCare by 0.8% in the 2nd quarter. Dimensional Fund Advisors LP now owns 714,253 shares of the company’s stock worth $82,930,000 after purchasing an additional 5,421 shares during the period. Argent Capital Management LLC raised its holdings in Addus HomeCare by 51.5% during the second quarter. Argent Capital Management LLC now owns 37,310 shares of the company’s stock valued at $4,332,000 after acquiring an additional 12,685 shares during the period. Point72 Asset Management L.P. grew its position in Addus HomeCare by 73.4% in the second quarter. Point72 Asset Management L.P. now owns 745,824 shares of the company’s stock worth $86,598,000 after acquiring an additional 315,602 shares in the last quarter. Finally, Victory Capital Management Inc. grew its position in Addus HomeCare by 136.5% in the second quarter. Victory Capital Management Inc. now owns 80,047 shares of the company’s stock worth $9,294,000 after acquiring an additional 46,199 shares in the last quarter. 95.35% of the stock is owned by hedge funds and other institutional investors.
Addus HomeCare Company Profile
Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.
See Also
- Five stocks we like better than Addus HomeCare
- What to Know About Investing in Penny Stocks
- Semtech Stock Climbs as AI Boom Drives Turnaround Success
- What Are Trending Stocks? Trending Stocks Explained
- 3 Companies Leading the Way With Aggressive Stock Buybacks
- What is a buyback in stocks? A comprehensive guide for investors
- Is It Time to Buy Nuclear Energy Stocks After the Latest Dip?
Receive News & Ratings for Addus HomeCare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Addus HomeCare and related companies with MarketBeat.com's FREE daily email newsletter.